Israel’s Brainsway reported positive final results in a clinical trial of its Deep TMS (transcanial magnetic stimulation) device for opening of the blood brain barrier in patients with malignant brain tumours. This is important for chemotherapy, and new therapies, in order to provide more focused delivery to improve their effectiveness.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000725879&fid=1725